3-9744393-GC-GCC

Variant names:

• chr3-9744393-G-GC
• rs762904815
• NM_001003694.2:c.2812dupC

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1 PP5 BS2

The NM_001003694.2(BRPF1):​c.2812dupC​(p.Gln938ProfsTer15) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,457,924 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.

• Frequency:
  • Genomes: not found (cov: 33)
  • Exomes 𝑓: 0.000011 (0 hom.)
• Consequence: BRPF1 NM_001003694.2 frameshift
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2 U:3
• Conservation: PhyloP100: 7.57

Genes affected

BRPF1 (HGNC:14255): (bromodomain and PHD finger containing 1) This gene encodes a bromodomain, PHD finger and chromo/Tudor-related Pro-Trp-Trp-Pro (PWWP) domain containing protein. The encoded protein is a component of the MOZ/MORF histone acetyltransferase complexes which function as a transcriptional regulators. This protein binds to the catalytic MYST domains of the MOZ and MORF proteins and may play a role in stimulating acetyltransferase and transcriptional activity of the complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

ACMG classification

Verdict is Uncertain_significance. Variant got 5 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PP5: Variant 3-9744393-G-GC is Pathogenic according to our data. Variant chr3-9744393-G-GC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 521797.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=3, Pathogenic=1}.
• BS2: High AC in GnomAdExome4 at 16 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
BRPF1	NM_001003694.2	c.2812dupC	p.Gln938ProfsTer15	frameshift_variant	Exon 9 of 14	ENST00000383829.7	NP_001003694.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
BRPF1	ENST00000383829.7	c.2812dupC	p.Gln938ProfsTer15	frameshift_variant	Exon 9 of 14	1	NM_001003694.2	ENSP00000373340.2

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome AF: 0.0000110 AC: 16 AN: 1457924 Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 4 AN XY: 725222

Gnomad4 AFR exome AF: 0.00

Gnomad4 AMR exome AF: 0.0000226

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.000227

Gnomad4 NFE exome AF: 0.00000180

Gnomad4 OTH exome AF: 0.0000166

GnomAD4 genome Cov.: 33

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:2 Uncertain:3

Revision: criteria provided, conflicting classifications

Submissions by phenotype

not provided Pathogenic:1 Uncertain:1

Aug 18, 2022

GeneDx

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge -

May 01, 2023

CeGaT Center for Human Genetics Tuebingen

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

BRPF1: PVS1 -

Inborn genetic diseases Pathogenic:1

May 18, 2017

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

not specified Uncertain:1

May 04, 2022

Mendelics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Intellectual developmental disorder with dysmorphic facies and ptosis Uncertain:1

Feb 09, 2021

Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The detected change is reported in the dbSNP database (dbSNP150) with the designation rs762904815. In gnomAD it is listed with a frequency of 0.005% (13/235928) (December 18, 2020). The change has already been entered once as pathogenic in ClinVar (RCV000623556.1). The variant leads to a frameshift. Nonsense and frameshift variants in the BRPF1 gene have already been described as disease causing in the literature (Mattioli et al., 2017; Yan et al., 2017). However, these are not subject to a full nonsense-mediated decay. A loss of function of the mutated allele could be shown in various patients, so that haploinsufficiency is assumed to be the underlying disease mechanism. Based on the current state of knowledge, the effect of the change demonstrated here cannot be predicted with certainty, so that, based on the current state of knowledge, the change can be classified as a "variant of uncertain clinical significance" (ACMG criteria). -

Computational scores

Source: dbNSFP v4.3

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs762904815; hg19: chr3-9786077;